Vascular Covered Stent Market Size, Sales, Average Price and Trends Analysis, till 2032

Vascular Covered Stent Market Size is estimated to be $262million in 2024 and is expected to grow at an average yearly rate of around 5.5% during the timeframe (2025-2032).

Monitor Country-wise Vascular Covered Stent Sales and Demand with Our Comprehensive Vascular Covered Stent Sales Database

Gain in-depth insights into the Vascular Covered Stent Sales landscape across 20+ countries with our specialized Vascular Covered Stent Sales Database. Stay ahead in the market by tracking country-wise Vascular Covered Stent Sales, identifying key manufacturers.

Extensive Vascular Covered Stent Sales database covering 20+ countries worldwide, Vascular Covered Stent Sales trends

Vascular Covered Stent market revenue tracker by country

Stay Updated with Vascular Covered Stent Sales Trends

Track real-time Vascular Covered Stent prices, analyze Vascular Covered Stent price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Vascular Covered Stent Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/vascular-covered-stent-market/

Vascular Covered Stent sales trend in 2024 vs 2025
The vascular covered stent market has witnessed a consistent upward trajectory, reflecting the increasing global demand for minimally invasive vascular interventions. A comparative look at the sales trends of 2024 and 2025 reveals several key factors influencing growth, including advancements in stent technology, higher incidences of vascular disorders, and evolving healthcare infrastructure in emerging markets.

Growth Pattern and Market Dynamics

In 2024, the vascular covered stent market showed steady growth, driven by rising cases of conditions like aortic aneurysms, peripheral artery disease, and trauma-related vascular injuries. The increased adoption of covered stents over traditional stents was largely due to their superior ability to seal off aneurysms and perforations in blood vessels. The sales figures reflected strong performance across both developed and developing regions, particularly in hospital settings where endovascular procedures are becoming more routine.

Moving into 2025, the market continues its upward momentum, with an estimated moderate increase in year-over-year sales. The rate of growth is fueled by broader acceptance of endovascular techniques and a growing geriatric population more susceptible to vascular diseases. Additionally, enhanced insurance coverage and reimbursement policies in many countries have helped boost patient access to these technologies.

Technological Innovation as a Growth Driver

The leap in sales from 2024 to 2025 can be significantly attributed to improvements in stent design and material innovation. Manufacturers are investing in research to develop stents with improved flexibility, radial strength, and compatibility with various anatomical complexities. For example, hybrid stents that combine the benefits of drug-eluting and covered stents are gaining attention, allowing for reduced restenosis and better patient outcomes.

These innovations not only contribute to clinical efficacy but also help reduce procedural times and hospital stays, making the use of covered stents more attractive to healthcare providers. By 2025, more next-generation products have entered the market, further increasing clinician confidence and market penetration.

Regional Trends and Market Segmentation

From a regional perspective, North America and Europe maintained their leadership in 2024 due to high healthcare expenditure, established medical infrastructure, and favorable regulatory environments. However, by 2025, the Asia-Pacific region shows notable acceleration in sales, spurred by expanding healthcare access, increased awareness of vascular health, and rising demand in populous nations such as China and India.

Market segmentation also shows a shift in usage. While aortic aneurysm repair continues to be a major application area, use in peripheral interventions is gaining ground. Hospitals remain the primary end users, but outpatient and ambulatory care centers are increasingly adopting these devices as procedural techniques become more simplified and cost-effective.

Challenges and Outlook

Despite the positive trend, the market faces certain challenges, including the high cost of covered stents, strict regulatory requirements, and limited access in rural areas. Nevertheless, these obstacles are gradually being addressed through strategic partnerships, localized manufacturing, and training initiatives aimed at increasing procedural expertise.

Request for customization https://datavagyanik.com/reports/vascular-covered-stent-market/

Vascular Covered Stent Market Definition

The vascular covered stent market refers to the global industry involved in the manufacturing, distribution, and utilization of covered stents specifically designed for vascular applications. These devices are critical in treating various vascular conditions such as aneurysms, arterial blockages, dissections, and traumatic vessel injuries. Covered stents, unlike traditional bare-metal stents, are equipped with a synthetic membrane or covering-typically made from materials like polytetrafluoroethylene (PTFE) or polyurethane-that offers enhanced sealing and isolation properties. This design helps prevent blood leakage through the vessel wall and reduces the risk of restenosis and other complications.

Understanding Vascular Covered Stents

A vascular covered stent is a tubular structure composed of a metal mesh scaffold (often stainless steel or nitinol) combined with a biocompatible covering. It is deployed inside blood vessels to reinforce the vessel wall and maintain blood flow while simultaneously sealing off damaged or diseased sections of the artery. These stents are primarily used in vascular and endovascular surgeries for conditions where both mechanical support and vessel sealing are required.

Typical applications include:

Aortic aneurysms, where the stent graft prevents rupture by isolating the aneurysm from blood pressure.

Arterial perforations or dissections, where the covering prevents bleeding and allows vessel healing.

Post-angioplasty complications, where a covered stent may be deployed to manage restenosis or rupture.

Market Components

The vascular covered stent market is segmented based on several factors, including product type, material, application, end user, and geography.

By product type, the market is divided into self-expanding and balloon-expandable covered stents.

By material, commonly used coverings include PTFE, ePTFE (expanded PTFE), and polyurethane.

By application, the market encompasses aortic aneurysm repair, peripheral artery disease, coronary artery disease, and trauma cases.

By end user, hospitals, specialty clinics, and ambulatory surgical centers are the key consumers of these devices.

Drivers of Market Growth

The market's expansion is fueled by a combination of technological advancements, increased awareness of vascular diseases, and growing demand for minimally invasive procedures. Aging populations, lifestyle-related conditions such as diabetes and hypertension, and rising healthcare investments have significantly increased the need for efficient vascular repair solutions. Covered stents are favored for their ability to reduce the risks associated with open surgeries, including infection, blood loss, and extended recovery periods.

Moreover, the development of more flexible, low-profile stents has broadened their applicability to complex anatomies and smaller vessels, allowing physicians to perform precise interventions with improved patient outcomes.

Challenges and Opportunities

Despite its promising growth, the vascular covered stent market faces several challenges. High device costs, regulatory complexities, and the need for trained personnel limit its penetration in lower-income regions. However, ongoing research, localized production strategies, and the expansion of healthcare infrastructure present substantial growth opportunities.



Important target segments driving the demand for Vascular Covered Stent Market

The vascular covered stent market is witnessing robust growth, primarily driven by demand from specific target segments within the healthcare industry. These segments are defined by patient demographics, disease prevalence, healthcare facility types, and clinical applications. Understanding these key segments is crucial for identifying market dynamics, product development strategies, and investment opportunities.

1. Geriatric Population

One of the most significant demand drivers for vascular covered stents is the growing global aging population. As individuals age, they become more susceptible to vascular conditions such as aortic aneurysms, peripheral artery disease (PAD), and arterial stenosis. These conditions often require endovascular interventions where covered stents offer both structural support and the ability to seal vessel tears or aneurysms. Since the risk of vascular complications increases significantly in people over the age of 65, this segment continues to represent a substantial portion of the market demand.

2. Patients with Peripheral Artery Disease (PAD)

Peripheral artery disease is a leading application area for vascular covered stents. PAD occurs when plaque builds up in the arteries, typically in the legs, reducing blood flow and potentially leading to severe complications such as ulcers, gangrene, and limb amputation. Covered stents are used to re-open blocked arteries while also providing a barrier against restenosis (re-narrowing of the artery). The rising prevalence of PAD, especially among diabetics and smokers, is creating strong demand for effective treatment solutions like covered stents.

3. Trauma and Emergency Care Units

Covered stents are also critical tools in trauma and emergency care settings, especially for vascular injuries caused by accidents, surgical complications, or spontaneous ruptures. In these high-stakes environments, covered stents are preferred over traditional surgical repair due to their rapid deployment, effectiveness in sealing bleeding vessels, and ability to stabilize patients quickly. Hospitals with trauma centers and emergency departments form a key consumer group in the covered stent market.

4. Hospitals and Specialty Clinics

The largest share of vascular covered stent usage takes place in hospitals and specialized cardiovascular clinics. These facilities have the infrastructure, skilled personnel, and diagnostic capabilities required for stent implantation procedures. Moreover, advancements in imaging and catheter-based technology have made these procedures more efficient, further increasing adoption in these clinical environments. Hospitals also tend to serve the most complex cases, including aortic aneurysm repairs and interventions in tortuous vessel anatomies, where covered stents are most beneficial.

5. Surgeons and Interventional Cardiologists

From a professional user perspective, interventional radiologists, cardiologists, and vascular surgeons are a key segment influencing demand. Their familiarity with newer stent technologies, access to ongoing training, and decision-making authority in choosing treatment modalities make them essential players in driving market growth. Their preference for covered stents is influenced by clinical outcomes, ease of deployment, and reduced procedure times.

Key Players in Vascular Covered Stent, Market Share

The vascular covered stent market is highly competitive and marked by the presence of several major global medical device manufacturers. These companies play a significant role in shaping the market through innovation, product diversification, global outreach, and strategic collaborations. As demand for minimally invasive vascular treatments continues to grow, key players are expanding their portfolios and strengthening their market positions to meet clinical needs across diverse regions.

1. Medtronic plc

Medtronic is one of the most influential players in the vascular covered stent market. With a wide range of endovascular and peripheral vascular devices, Medtronic's covered stents are widely used in treating complex aortic and peripheral artery diseases. The company is known for its robust research and development initiatives, which consistently bring forward cutting-edge solutions. Medtronic holds a significant market share due to its global presence, trusted brand, and integration of stents into broader vascular treatment systems.

2. Boston Scientific Corporation

Boston Scientific has established itself as a key competitor through continuous innovation and a strong focus on minimally invasive technologies. Their vascular stents are known for their deliverability, strength, and clinical success rates. The company's covered stents are used across a variety of indications, including peripheral artery interventions and emergency vascular repairs. Boston Scientific's strong sales network and strategic acquisitions help it maintain a substantial share of the global market.

3. W. L. Gore & Associates, Inc.

W. L. Gore is a recognized leader in the development of expanded polytetrafluoroethylene (ePTFE) covered stents. Its stent graft products, particularly in the treatment of aortic aneurysms and peripheral vascular disease, are widely adopted in clinical practice. The company emphasizes durability, flexibility, and low complication rates, making it a preferred choice for many vascular surgeons. Gore's specialized expertise in materials science gives it a competitive edge in the covered stent segment.

4. Cook Medical

Cook Medical is known for its tailored solutions in vascular interventions. Its covered stents are used in both large vessel and peripheral procedures. With a focus on minimally invasive technology, Cook continues to grow its market share by offering user-friendly devices and clinical education programs. Their stents are often praised for their compatibility with a variety of delivery systems, aiding in complex interventions.

5. Terumo Corporation

A major player based in Japan, Terumo has made significant strides in the vascular covered stent market. The company offers a range of interventional products with a growing presence in covered stents. Terumo's investment in research and its increasing visibility in global markets position it as an emerging leader. The company continues to gain market share in Asia and other developing regions through affordability and innovation.

6. BD (Becton, Dickinson and Company)

Following its acquisition of C.R. Bard, BD significantly expanded its vascular product offerings, including covered stents. The integration has strengthened BD's position, especially in the U.S. market. With strong distribution and service capabilities, BD is increasing its global share in both hospital and outpatient care settings.



Key Questions Answered in the Vascular Covered Stent market report:

What is the total global Vascular Covered Stent Sales volume, and how has it changed over the past five years?

What is Vascular Covered Stent price trend, what has been the historical prices?

What will be the Vascular Covered Stent price trend in 2025?

Which countries have the highest Vascular Covered Stent Sales, and what factors contribute to their dominance in the market?

How does Vascular Covered Stent Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Vascular Covered Stent Sales, and how does it compare to previous years?

Which industries drive the highest demand for Vascular Covered Stent, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Vascular Covered Stent Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Vascular Covered Stent Sales and market dynamics?

Related Studies:

Non-invasive Ventilation (NIV) Helmets Market
https://datavagyanik.com/reports/non-invasive-ventilation-niv-helmets-market/

Scalp Cooling Systems for Chemotherapy Patients Market
https://datavagyanik.com/reports/scalp-cooling-systems-for-chemotherapy-patients-market/


Argon Plasma Coagulator Market
https://datavagyanik.com/reports/argon-plasma-coagulator-market/

Phrenic Nerve Stimulation Devices Market
https://datavagyanik.com/reports/phrenic-nerve-stimulation-devices-market/

Endovenous Laser Therapy (EVLT) Devices Market
https://datavagyanik.com/reports/endovenous-laser-therapy-evlt-devices-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/Email: sales@datavagyanik.com

This release was published on openPR.